Table 4.
Prevalence of long COVID symptoms in studies investigating patients regardless of disease severity and in studies in hospitalized patients [23,25,28,47,55,74,[122], [123], [124], [125], [126], [127], [128], [129], [130], [131], [132], [133], [134], [135], [136], [137], [138], [139], [140]]
| Symptom | All patients (%) | Hospitalized (%) | Outpatients (%) | |
|---|---|---|---|---|
| General | Fever/feverish | 0.05–6.8 | 10.4 | 1.41 |
| Fatigue | 4–73.2 | 17.5–54.5 | 24.6 | |
| Headache | 0.05–47.4 | 24.6 | 8.8 | |
| Chest pain/tightness | 3.1–31.7 | 0.4–17.9 | 14.6 | |
| Musculoskeletal | Joint pain/arthralgia | 9–37.3 | 5.9–28.6 | 9.3 |
| Myalgia | 2–44.9 | 37.4–47.8 | 10.8 | |
| Respiratory | Dyspnoea | 21.8–39 | 5.5–59.7 | 13.7 |
| Exertional dyspnoea | 39–54.8 | 14.6–57.1 | ||
| Cough | 3.2–23.4 | 2.5–35.1 | 6 | |
| Sleep apnoea | 24–35.7 | 30.8–35.1 | — | |
| Throat pain | 4–19 | 4.4 | ||
| Gustatory | Ageusia/dysgeusia | 7–16.1 | 9–21.6 | 16.8 |
| Anosmia | 11–45 | 4.6–26.1 | 22.2 | |
| Loss of appetite | 8–10.2 | — | — | |
| Neuropsychological | Confusion/brain fog | 3–63.3 | — | 15.6 |
| Depression | 11–15.7 | — | — | |
| Sleep disorder | 24–35.7 | — | — | |
| Posttraumatic stress disorder | — | 5.8–10.4 | 7 | |
| Cardiovascular | Palpitations | 3.9–40 | — | 7.3 |
| Skin | Rash | 3–35.7 | — | 1.6 |